Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Study of people with REM sleep behavior disorder who may develop Parkinson disease

Enrolls people with a sleep disorder linked to Parkinson-type brain diseases to prepare future trials.

Plain-language title generated from the registry record
Registry title: North American Prodromal Synucleinopathy Consortium

Key facts

Where
Montreal, CanadaSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with idiopathic REM sleep behavior disorder (RBD), to prepare for a later trial of treatments that protect the nerves.

Age
18 Years and older
Sex
All sexes can join.
Disease stage
Idiopathic REM sleep behavior disorder (no other known cause).

Main reasons for not taking part

  • REM sleep behavior disorder caused by another condition (for example narcolepsy, dementia, Parkinson's Disease)
  • Another neurological disorder

Read by machine on 12 November 2026.

Where in Canada

  • McGill UniversityMontreal, CanadaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Washington University School of Medicine
Trial code
NCT03623672
Record updated
6 November 2024
Original description
This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.Read full original descriptionShow less

North American Prodromal Synucleinopathy Consortium

This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.

Inclusion: Idiopathic REM sleep behavior disorder.

Exclusion: REM sleep behavior disorder secondary to another cause (ex: narcolepsy, dementia, Parkinson's Disease, etc); Other neurological disorder.

ClinicalTrials.gov NCT03623672